Compile Data Set for Download or QSAR
Report error Found 7 Enz. Inhib. hit(s) with all data for entry = 10068
TargetNuclear receptor ROR-gamma(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM50502388(CHEMBL4525318 | US11084784, Example 1)
Affinity DataIC50: 25nMAssay Description:CHO-K1 cells stably transfected with ROR t are maintained in MEM-EBS with 5% FBS, 1% penicillin streptomycin solution and 1 mg/mL G418. The cells are...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM50502407(CHEMBL4549060 | US11084784, Example 13)
Affinity DataIC50: 25nMAssay Description:CHO-K1 cells stably transfected with ROR t are maintained in MEM-EBS with 5% FBS, 1% penicillin streptomycin solution and 1 mg/mL G418. The cells are...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM511694(US11084784, Example 24)
Affinity DataIC50: 25nMAssay Description:CHO-K1 cells stably transfected with ROR t are maintained in MEM-EBS with 5% FBS, 1% penicillin streptomycin solution and 1 mg/mL G418. The cells are...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM511695(US11084784, Example 25)
Affinity DataIC50: 25nMAssay Description:CHO-K1 cells stably transfected with ROR t are maintained in MEM-EBS with 5% FBS, 1% penicillin streptomycin solution and 1 mg/mL G418. The cells are...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM511696(US11084784, Example 34)
Affinity DataIC50: 25nMAssay Description:CHO-K1 cells stably transfected with ROR t are maintained in MEM-EBS with 5% FBS, 1% penicillin streptomycin solution and 1 mg/mL G418. The cells are...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM511697(US11084784, Example 43)
Affinity DataIC50: 25nMAssay Description:CHO-K1 cells stably transfected with ROR t are maintained in MEM-EBS with 5% FBS, 1% penicillin streptomycin solution and 1 mg/mL G418. The cells are...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Piramal Enterprises

US Patent
LigandPNGBDBM511693(US11084784, Example 23)
Affinity DataIC50: 75nMAssay Description:CHO-K1 cells stably transfected with ROR t are maintained in MEM-EBS with 5% FBS, 1% penicillin streptomycin solution and 1 mg/mL G418. The cells are...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent